BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17016575)

  • 1. Anticancer effect of lysine, proline, arginine, ascorbic acid and green tea extract on human renal adenocarcinoma line 786-0.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Oncol Rep; 2006 Nov; 16(5):943-7. PubMed ID: 17016575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Int J Urol; 2006 Apr; 13(4):415-9. PubMed ID: 16734861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro antitumor effect of a unique nutrient mixture on lung cancer cell line A-549.
    Waheed Roomi M; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Exp Lung Res; 2006 Oct; 32(9):441-53. PubMed ID: 17162651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of matrix metalloproteinase-2 secretion and invasion by human ovarian cancer cell line SK-OV-3 with lysine, proline, arginine, ascorbic acid and green tea extract.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    J Obstet Gynaecol Res; 2006 Apr; 32(2):148-54. PubMed ID: 16594917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of a nutrient mixture on human testicular cancer cell line NT 2/DT matrigel invasion and MMP activity.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Med Oncol; 2007; 24(2):183-8. PubMed ID: 17848742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Oncol Rep; 2005 Dec; 14(6):1399-404. PubMed ID: 16273231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked inhibition of growth and invasive parameters of head and neck squamous carcinoma FaDu by a nutrient mixture.
    Roomi MW; Roomi NW; Kalinovsky T; Rath M; Niedzwiecki A
    Integr Cancer Ther; 2009 Jun; 8(2):168-76. PubMed ID: 19679626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():251-64. PubMed ID: 17564322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of malignant mesothelioma cell matrix metalloproteinase production and invasion by a novel nutrient mixture.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Exp Lung Res; 2006; 32(3-4):69-79. PubMed ID: 16754473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline and green tea extract on human melanoma cell line A2058.
    Roomi MW; Ivanov V; Netke S; Kalinovsky T; Niedzwiecki A; Rath M
    In Vivo; 2006; 20(1):25-32. PubMed ID: 16433024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145.
    Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2011 Dec; 26(6):1407-13. PubMed ID: 21874261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of human cervical cancer cell lines Hela and DoTc2 4510 by a mixture of lysine, proline, ascorbic acid, and green tea extract.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Int J Gynecol Cancer; 2006; 16(3):1241-7. PubMed ID: 16803512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of growth and expression of inflammation mediators in human leukemic cell line U-937 by a nutrient mixture.
    Roomi MW; Kalinovsky T; Roomi NW; Rath M; Niedzwiecki A
    Exp Oncol; 2013 Sep; 35(3):180-6. PubMed ID: 24084455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Oncol Rep; 2005 Feb; 13(2):253-7. PubMed ID: 15643507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis.
    Roomi MW; Roomi N; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Oncol Rep; 2005 Oct; 14(4):807-15. PubMed ID: 16142336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-atherogenic effects of a mixture of ascorbic acid, lysine, proline, arginine, cysteine, and green tea phenolics in human aortic smooth muscle cells.
    Ivanov V; Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):140-5. PubMed ID: 17414225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines.
    Roomi MW; Kalinovsky T; Roomi NW; Rath M; Niedzwiecki A
    Oncol Rep; 2012 Jan; 27(1):17-27. PubMed ID: 21947138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
    Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
    Int J Oncol; 2014 Mar; 44(3):986-92. PubMed ID: 24378964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effects of matrix metalloproteinase (MMP) inhibitor LY52 on expression of MMP-2 and MMP-9 and invasive ability of human ovarian carcinoma cell line SKOV3].
    Yuan YX; Xu WF; Liu J; Chen MH; Meng H; Qu XJ
    Ai Zheng; 2006 Jun; 25(6):663-70. PubMed ID: 16764758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.
    Roomi MW; Monterrey JC; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2010 Sep; 24(3):747-57. PubMed ID: 20664983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.